Protein precipitation: a volume of 400 μl of a urine sample was homogenised with 900 μl of cold deuterated methanol in Eppendorf tubes and stored at -20⁰C overnight. After centrifugation for 10 minutes at 13,000 g, the supernatants were collected in different Eppendorfs tubes. Protein pellets and supernatants were dried-down in a speed vac overnight. The dried fraction from the supernatant was reconstituted in 400 μl of water, from which 100 μl was used for protein measurement and 300 μl for NMR analysis. Dried protein pellets were re-suspended with 40 μl of water prior to protein measurement.
MATERIAL AND METHODS:
Protein precipitation: a volume of 400 μl of a urine sample was homogenised with 900 μl of cold deuterated methanol in Eppendorf tubes and stored at -20⁰C overnight. After centrifugation for 10 minutes at 13,000 g, the supernatants were collected in different Eppendorfs tubes. Protein pellets and supernatants were dried-down in a speed vac overnight. The dried fraction from the supernatant was reconstituted in 400 μl of water, from which 100 μl was used for protein measurement and 300 μl for NMR analysis. Dried protein pellets were re-suspended with 40 μl of water prior to protein measurement.
Protein measurement: Urinary protein was quantified using the Pierce 660 nm protein assay kit (Thermo, Rockford, USA). Protein concentration was calculated by using a standard curve of bovine serum albumin (BSA) at different concentrations (dynamic range 0-20 mg/ml). For each urine sample, protein concentration was assessed in an intact aliquot, in an aliquot diluted with water (1:10) and from a re-suspended-protein pellet (sample concentrated 10 times) to overcome the dynamic range limitations of the assay. A volume of 10 μl of a urine sample or BSA standard was combined and mixed in 150 μl of protein reagent in a well of a 96-well plate. After 10 minutes of incubation (for the colour reaction), the absorption at 660 nm was measured. Each measurement was performed in triplicate on the same 96 well plate.
RESULTS:
Comparison of 1 H NMR spectra processed with median fold change (MFC) or total area normalisation
The volume and concentration of urine are not controlled and depend on the individual's hydration status. Therefore, a normalisation procedure is a critical step to partially account for dilution differences in order to achieve a high quality and reproducible dataset. In the present study, the MFC normalisation and total area normalisation was compared in the 1 H NMR dataset before or after PI peak removal (Supplementary Figure 4) .
When the MFC normalisation was applied before or after PI peak removal, no change in the comparison between iMN and NC or PI -vs PI + samples were observed. (Supplementary Figure 4E , 4F, 4G, 4H), which means that the MFC normalisation method is not affected by the presence of contaminant peaks. On the other hand, when the 1 H NMR data were normalised based on total area normalisation before removing the PI peaks, a natural separation between NC and NC+PI and between iMN and iMN+PI samples was found by PCA (Supplementary Figure 4A) . Direct comparison of the NMR spectra highlighted an increase of peak area in urine samples containing PI when the spectra were normalised to total area (Supplementary Figure 4B) . This common normalisation methods is based on the adjustment of each NMR data point intensity by normalisation to the total data point area in the whole spectrum. . However, when large peaks from proteins, or contaminants such as PI, are present in the urine, this normalisation method introduces intensity artefacts and may increase false positives in biomarker discovery. With this in mind, the total area normalisation of this data set must be achieved after careful removal of PI contaminant peaks (Supplementary Figure 4C, 4D) . Alternatively, the MFC normalisation calculated the median of the log fold change of the peak intensities between a specific sample and a target sample and adjust the log fold change to approximately 0. The targeted sample is typically the median spectrum in a set of experiment. This normalisation method is based on the statement that metabolites peaks uniquely affected by dilution confer the same fold change. The calculated median fold changes corresponds to the most probable dilution factor for each 1 H NMR spectrum. This method is known to be robust even with the 4 presence of by high intensity resonances in the spectra. In our study, there is no significant difference in PCA score plot when the data have been MFC normalised either prior to or after contaminant peak removal ( Figure S4 E, G), indicating that the method is not affected by the presence of PI peaks. .. In general, the MFC normalisation is the most suitable method to correct for dilution effects in 1 H NMR urine profiles of iMN patients, which may contain large peaks from proteins, drugs and their metabolites, as well as additives from sample preparation. The MFC-normalised 1 H NMR data after PI peak removal was therefore selected prior to carrying out the statistical analysis. Table S1 : Published list of the chemicals present in the protease inhibitor from Roche. before or after removal of PI contaminant peaks on group clustering and peak shape. PCA score plots based on NMR spectra from the iMN, iMN+PI, NC and NC+PI groups, using total area normalisation prior to PI peak removal (A) or after PI peak removal (C), or MFC normalised data prior to PI peak removal (E) and after PI peak removal (G). Comparison of the NMR peak shape of hippurate at 7.59 ppm in the spectra of urine from the iMN, iMN+PI, NC and NC+PI groups using total area normalised data prior to PI peak removal (B) or after PI peak removal (D), or MFC normalised data prior to PI peak removal (F) and after PI peak 
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